VVOS Vivos Therapeutics, Inc.

Fundamentals / CIK 0001716166 / USD

Vivos Therapeutics, Inc. reported $20.53M in revenue and a net loss of $22.00M for the trailing twelve months ended September 30, 2026 (down 5.4% year over year), with a 60.0% gross margin and a -105.8% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open VVOS in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

7 fiscal years (2019 to 2025), reported in USD.

$19.71M$9.85M$0-$23.78MFY 2019 Revenue: $11.39MFY 2019 Net Income: -$10.75M2019FY 2020 Revenue: $13.07MFY 2020 Net Income: -$12.06M2020FY 2021 Revenue: $16.89MFY 2021 Net Income: -$20.29M2021FY 2022 Revenue: $16.02MFY 2022 Net Income: -$23.84M2022FY 2023 Revenue: $13.80MFY 2023 Net Income: -$13.58M2023FY 2024 Revenue: $15.03MFY 2024 Net Income: -$11.14M2024FY 2025 Revenue: $17.44MFY 2025 Net Income: -$21.17M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $17.44M $15.03M $13.80M $16.02M $16.89M $13.07M $11.39M
Cost of Revenue $6.90M $6.01M $5.53M $200K $400K $100K $2.74M
Gross Profit $10.54M $9.02M $8.27M $10.02M $12.60M $10.41M $8.66M
Research & Development $100K $100K $100K $200K $200K -- --
Selling, General & Admin $29.13M $19.61M $24.95M $34.38M $31.34M $18.40M $18.48M
Total Operating Expenses $30.44M $20.19M $25.57M $35.05M $32.99M $22.45M $19.23M
Operating Income -$19.89M -$11.17M -$17.30M -$25.03M -$20.38M -$12.04M -$10.58M
EBITDA -$18.59M -$10.59M -$16.68M -$24.36M -$19.65M -$11.32M -$9.83M
Interest Income -- -- -- -- $117K $79K $21K
Interest Expense $1.40M -- -- -- $14K $96K $138K
Income Before Tax -$21.23M -$11.14M -$13.58M -$23.84M -$20.29M -$12.06M -$10.75M
Net Income -$21.17M -$11.14M -$13.58M -$23.84M -$20.29M -$12.06M -$10.75M
Basic EPS -$2.07 -$2.22 -$11.14 -$647.50 -$24.00 -$35.00 -$23.75
Diluted EPS -$2.07 -$2.22 -$11.14 -$647.50 -$24.00 -$35.00 -$23.75
Basic Shares Outstanding 10.3M 5.0M 1.2M 36.8K 849.3M 514.8K 493.3K
Diluted Shares Outstanding 10.3M 5.0M 1.2M 36.8K 849.3K 514.8K 493.3K

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $6.41M $5.15M $5.14M $3.82M $6.78M $3.82M $3.02M $3.70M
Cost of Revenue $3.10M $2.20M $2.08M $836K $2.85M $1.71M $1.51M $1.60M
Gross Profit $3.31M $2.95M $3.06M $2.99M $3.94M $2.11M $1.51M $2.10M
Selling, General & Admin $6.66M $7.27M $9.22M $8.93M $8.29M $6.67M $5.25M $4.76M
Total Operating Expenses $7.21M $7.78M $9.67M $9.37M $8.67M $6.97M $5.43M $4.90M
Operating Income -$3.90M -$4.83M -$6.62M -$6.38M -$4.73M -$4.87M -$3.92M -$2.81M
EBITDA -$3.35M -$4.32M -$6.16M -$5.94M -$4.35M -$4.56M -$3.74M -$2.66M
Interest Expense $600K $1.10M $1.10M -- $500K -- -- --
Income Before Tax -$1.97M -$5.52M -$7.75M -$6.95M -$5.40M -$5.01M -$3.86M -$2.83M
Net Income -$1.95M -$5.48M -$7.68M -$6.89M -$5.40M -$5.01M -$3.86M -$2.83M
Basic EPS -$0.07 -$0.31 -$0.52 -- -$0.49 -$0.55 -$0.45 --
Diluted EPS -$0.07 -$0.31 -$0.52 -- -$0.49 -$0.55 -$0.45 --
Basic Shares Outstanding 26.5M 17.7M 14.6M -- 11.0M 9.1M 8.6M --
Diluted Shares Outstanding 26.5M 17.7M 14.6M -- 11.0M 9.1M 8.6M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $2.03M $6.26M $1.64M $3.52M $24.03M $18.21M $469K
Cash & Short-Term Investments $2.03M $6.26M $1.64M $3.52M $24.03M $18.21M $469K
Accounts Receivable, Net $1.58M $430K $202K $457K $1.20M $1.43M $871K
Total Current Assets $4.38M $7.47M $2.46M $5.42M $27.32M $20.39M $1.98M
Property, Plant & Equipment, Net $3.76M $3.31M $3.31M $3.08M $2.83M $872K $1.14M
Goodwill $8.57M $2.84M $2.84M $2.84M $2.84M $2.67M $2.67M
Intangible Assets $4.04M $409K $420K $302K $341K $270K $689K
Total Non-Current Assets $20.77M $7.81M $8.27M $8.30M $6.37M $4.93M $5.57M
Total Assets $25.15M $15.28M $10.73M $13.72M $33.69M $25.33M $7.55M
Accounts Payable $1.68M $1.10M $2.15M $1.41M $920K $781K $1.08M
Short-Term Debt $8.35M -- -- -- $1.26M $867K $3.71M
Deferred Revenue (Current) $479K $896K $2.14M $2.93M $2.40M $2.94M $2.95M
Other Current Liabilities $850K $273K $198K $145K -- -- --
Total Current Liabilities $18.08M $4.98M $7.29M $6.81M $7.51M $7.84M $9.09M
Long-Term Debt $469K $1.20M $1.20M -- $0 $423K $0
Deferred Revenue (Non-Current) -- $97K $289K $112K -- -- --
Other Non-Current Liabilities $1.30M -- -- -- -- -- --
Total Non-Current Liabilities $8.63M $2.35M $3.03M $2.11M $641K $569K $84K
Total Liabilities $26.70M $7.33M $10.32M $8.92M $8.15M $8.41M $9.18M
Total Debt (incl. Leases) $13.50M $2.71M $3.19M $2.41M $1.98M $1.29M $3.71M
Common Stock $1.0K -- -- $2.0K $2.0K $2.0K $1.2K
Retained Earnings -$125.4M -$104.2M -$93.05M -$79.47M -$55.62M -$35.34M -$23.28M
Total Stockholders' Equity -$1.49M $7.95M $411K $4.80M $25.54M $16.92M -$2.94M
Total Equity -$1.55M $7.95M $411K $4.80M $25.54M $16.92M -$2.94M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $247K $1.77M $2.11M $2.03M $3.09M $4.40M $2.34M $6.26M
Cash & Short-Term Investments $247K $1.77M $2.11M $2.03M $3.09M $4.40M $2.34M $6.26M
Accounts Receivable, Net $2.37M $1.44M $1.77M $1.58M $2.13M $1.63M $718K $430K
Total Current Assets $3.51M $4.21M $4.82M $4.38M $5.79M $6.73M $3.61M $7.47M
Property, Plant & Equipment, Net $3.35M $3.64M $3.53M $3.76M $5.64M $5.13M $3.31M $3.31M
Goodwill $8.57M $8.57M $8.57M $8.57M $8.45M $8.45M $2.84M $2.84M
Intangible Assets $3.44M $3.64M $3.84M $4.04M $2.17M $2.23M $358K $409K
Total Non-Current Assets $19.35M $19.93M $20.22M $20.77M $19.86M $19.30M $7.67M $7.81M
Total Assets $22.86M $24.14M $25.04M $25.15M $25.64M $26.03M $11.28M $15.28M
Accounts Payable $2.74M $2.95M $2.00M $1.68M $2.10M $1.76M $1.21M $1.10M
Short-Term Debt $1.50M $7.77M $7.30M $8.35M $339K $157K -- --
Deferred Revenue (Current) $72K $583K $495K $479K $537K $480K $572K $896K
Other Current Liabilities $2.12M $1.20M $1.23M $850K $987K $1.01M $672K $273K
Total Current Liabilities $16.16M $20.39M $17.94M $18.08M $7.44M $6.43M $4.70M $4.98M
Long-Term Debt $313K $366K $418K $469K $8.38M $7.76M -- $1.20M
Deferred Revenue (Non-Current) -- -- -- -- $1.0K $5.0K $22K $97K
Other Non-Current Liabilities $950K $950K $1.30M $1.30M $1.40M $1.40M -- --
Total Non-Current Liabilities $4.53M $7.74M $8.37M $8.63M $15.68M $15.02M $2.17M $2.35M
Total Liabilities $20.69M $28.13M $26.31M $26.70M $23.11M $21.45M $6.88M $7.33M
Total Debt (incl. Leases) $5.99M $12.51M $12.27M $13.50M $12.50M $11.58M $1.40M $2.71M
Common Stock $3.0K $1.0K $1.0K $1.0K $1.0K -- -- --
Retained Earnings -$140.5M -$138.5M -$133.0M -$125.4M -$118.5M -$113.1M -$108.1M -$104.2M
Total Stockholders' Equity $2.36M -$3.81M -$1.14M -$1.49M $2.53M $4.58M $4.41M $7.95M
Total Equity $2.16M -$3.99M -$1.27M -$1.55M $2.53M $4.58M $4.41M $7.95M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$21.23M -$11.14M -$13.58M -$23.84M -$20.29M -$12.06M -$10.75M
Depreciation & Amortization $1.31M $581K $621K $669K $733K $718K $751K
Stock-Based Compensation $661K $762K $1.11M $2.40M $2.66M $2.17M $1.99M
Change in Receivables -$217K -$228K $255K $746K $228K -$560K -$276K
Change in Payables $524K -$1.05M $734K $491K $139K -$274K $548K
Operating Cash Flow -$15.26M -$12.69M -$11.95M -$19.59M -$15.73M -$5.68M -$5.34M
Capital Expenditure -$2.34M -$568K -$803K -$924K -$2.40M -$120K -$176K
Free Cash Flow -$17.60M -$13.26M -$12.75M -$20.51M -$18.13M -$5.80M -$5.52M
Acquisitions, Net -- -- -- -- -$225K -- --
Investing Cash Flow -$7.53M -$568K -$853K -$924K -$2.61M -$120K $86K
Common Stock Issued $5.58M $7.80M $4.00M -- $27.93M $22.29M $1.25M
Financing Cash Flow $18.56M $17.88M $10.92M -- $24.17M $23.54M $4.47M
Net Change in Cash -$4.23M $4.62M -$1.88M -$20.51M $5.82M $17.74M -$785K

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$1.97M -$5.52M -$7.75M -$6.95M -$5.40M -$5.01M -$3.86M -$2.83M
Depreciation & Amortization $550K $510K $454K $442K $384K $306K $177K $144K
Stock-Based Compensation $76K $50K $151K $47K $55K $242K $317K $57K
Change in Receivables -$932K $331K -$188K $553K -$501K $19K -$288K $24K
Change in Payables -$208K $950K $318K -$424K $340K $499K $109K $22K
Operating Cash Flow -$3.18M -$3.15M -$6.01M -$3.81M -$4.16M -$3.49M -$3.80M -$2.94M
Capital Expenditure -$61K -$416K -$18K -$1.53M $83K -$771K -$122K -$165K
Free Cash Flow -$3.24M -$3.56M -$6.03M -$5.34M -$4.08M -$4.26M -$3.92M -$3.10M
Investing Cash Flow -$61K -$416K -$18K -$1.58M $83K -$5.91M -$122K -$165K
Common Stock Issued $302K $291K $342K -- -- -- -- --
Financing Cash Flow $1.71M $3.23M $6.11M -- -- -- -- $3.05M
Net Change in Cash -$1.53M -$336K $81K -$1.06M -$1.31M $2.06M -$3.92M -$51K

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Gross Margin 60.4% 60.0% 59.9% 62.5% 74.6% 79.7% 76.0%
Operating Margin -114.1% -74.3% -125.3% -156.2% -120.7% -92.1% -92.8%
Net Profit Margin -121.4% -74.1% -98.4% -148.8% -120.2% -92.3% -94.4%
Return on Equity (ROE) -- -140.0% -3304.9% -496.7% -79.4% -71.3% --
Return on Assets (ROA) -84.2% -72.9% -126.6% -173.8% -60.2% -47.6% -142.4%
Current Ratio 0.24x 1.50x 0.34x 0.80x 3.64x 2.60x 0.22x
Quick Ratio 0.20x 1.34x 0.25x 0.58x 3.36x 2.50x 0.15x
Debt to Equity -- 0.34x 7.77x 0.50x 0.08x 0.08x --
Revenue Growth (YoY) +16.0% +8.9% -13.9% -5.1% +29.2% +14.7% --
Gross Profit Growth (YoY) +16.9% +9.0% -17.4% -20.5% +21.0% +20.3% --
5Y Revenue / Share Growth -93.3% -87.0% -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Gross Margin 60.0% 61.9% 61.8% 60.4% 55.7% 55.9% 58.7% 60.0%
Operating Margin -105.8% -107.9% -115.5% -114.1% -94.3% -98.9% -77.3% -74.3%
Net Profit Margin -107.2% -121.8% -127.7% -121.4% -98.8% -99.5% -76.8% -74.1%
Return on Equity (ROE) -932.3% -- -- -- -675.5% -312.5% -255.0% -140.0%
Return on Assets (ROA) -96.3% -105.4% -99.8% -84.2% -66.7% -55.0% -99.6% -72.9%
Current Ratio 0.22x 0.21x 0.27x 0.24x 0.78x 1.05x 0.77x 1.50x
Quick Ratio 0.16x 0.16x 0.22x 0.20x 0.70x 0.94x 0.65x 1.34x
Debt to Equity 2.54x -- -- -- 4.94x 2.53x 0.32x 0.34x
Revenue Growth (YoY) -5.4% +34.9% +70.5% +3.4% +75.7% -5.8% -11.8% +13.9%
Gross Profit Growth (YoY) -15.8% +40.0% +102.7% +42.5% +68.7% -20.4% -22.1% +0.4%
Source: SEC EDGAR CompanyFacts (CIK 0001716166) · from December 31, 2019 Data through September 30, 2026 · synced Nov 21, 2026, 05:13 UTC · Open in terminal